No Data
No Data
Saisheng Pharmaceutical (06600): 31,000 share options have been exercised
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on May 31, 2024, the 31,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical announced that the 28,500 share options granted have been exercised
Saisheng Pharmaceutical (06600) announced that on May 30, 2024, the 28,500 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical (06600): 28,500 share options have been exercised
Saisheng Pharmaceutical (06600) issued an announcement. On May 30, 2024, according to the initial public offering after-sales share purchase options...
Saisheng Pharmaceutical (06600.HK): Offeror received a non-binding letter of support from Pentwater for 29.25 million shares
Gelonghui, May 29丨Saisheng Pharmaceutical (06600.HK) issued an announcement. On May 29, 2024, the offender received a non-binding letter of support from Pentwater Capital Management Europe LLP (Pentwater) for 29.25 million shares (approximately 4.64% of the company's issued share capital at the date of this announcement and 8.51% of the issued share capital of the company held by uninterested shareholders, and all shares held by Waterpent on the date of this announcement) , confirming that it will be proposed by the court
Saisheng Pharmaceutical announced that the 390,000 share options granted have been exercised
Saisheng Pharmaceutical (06600) announced that on May 28, 2024, 250,000 share options granted under the share option incentive plan have been exercised in accordance with the rules of the share option incentive plan, and the 140,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical (06600): 390,000 share options exercised
Saisheng Pharmaceutical (06600) announced that on May 28, 2024, 250,000 will be awarded under the share purchase incentive plan...
No Data